Angiotensin-I-Converting Enzyme and Gallium Scan in Noninvasive Evaluation of Sarcoidosis

  1. AILEEN NOSAL, M.D.;
  2. LEOPOLD A. SCHLEISSNER, M.D.;
  3. FRED S. MISHKIN, M.D.; and
  4. JACK LIEBERMAN, M.D.
  1. Torrance, California

    Abstract

    Angiotensin-converting enzyme assays and gallium-scan results were obtained from 27 patients with biopsy-proven, clinically active sarcoidosis. Twenty-three of these patients had elevated converting enzyme levels, and 22 had positive gallium-scan results. Three of four patients with normal or borderline-elevated levels of angiotensin-converting enzyme also had positive gallium-scan results. Of 156 nonsarcoid patients (pulmonary and other diseases), 27 were found to have elevated serum converting enzyme levels, and 25 of these had negative gallium-scan results. These results indicate that the combination of an assay of angiotensin-converting enzyme and gallium scan increases diagnostic specificity from 83% to 99% without sacrificing sensitivity. We conclude that the concurrent use of angiotensin-converting enzyme assay and gallium scan is of value in the diagnosis of sarcoidosis.

    Article and Author Information

    • ▸From the Harbor/UCLA Medical Center, Torrance; Martin Luther King, Jr. Hospital, Los Angeles; and Veterans Administration Hospital, Sepulveda, California.

    • ▸Requests for reprints should be addressed to Aileen Nosal, M.D.; Outpatient Chest Services, Harbor General Hospital, Chest Disease Referral Center; 1000 West Carson Street, Building C-4; Torrance, CA 90509.

      • Received May 5, 1978.
      • Accepted December 8, 1978.
    « Previous | Next Article »Table of Contents